Header graphic for print
Biosimilars Law Blog

Monthly Archives: June 2017

Posted in News & Events

Biosimilars Presentation at Sino-American Pharmaceutical Conference

On June 24, 2017, Hogan Lovells attorneys Xin Tao (Washington DC Office) and Liang Xu (Beijing Office) spoke at the 15th Annual Conference of the Sino-American Pharmaceutical Professionals Association – Greater Philadelphia’s annual conference. Mr. Tao presented on the “Biosimilar Exclusivity and Interchangeability: A Legal Primer” for both innovators and biosimilar applicants. Mr. Liang presented

Posted in Biosimilars Patent Exchange, News & Events

Supreme Court Issues Landmark Biosimilar Ruling

On June 12, 2017, the Supreme Court issued a unanimous ruling in Sandoz Inc. v. Amgen Inc. The case interprets two provisions of the Biologics Price Competition and Innovation Act of 2009 (BPCIA) and is expected to significantly impact the approval and patent litigation processes for biosimilar applications. First, the BPCIA requires a biosimilar applicant